title: [Octreotide in the diagnosis and treatment of pituitary thyrotropin-secreting adenoma].
abstract: OBJECTIVE
  To evaluate the efficacy of octreotide in the diagnosis and treatment of pituitary thyrotropin (TSH)-secreting adenoma.
  
  
  METHODS
  A 34-year man presented with central hyperthyroidism and pituitary TSH-secreting macroadenoma was reported. (99 m)Tc-octreotide scan and magnetic resonance imaging were completed to make the location diagnosis of the adenoma. Octreotide in 0.1 mg dose was subcutaneously injected every 8 hours for 10 days. Serum TSH level and tumor size were observed and trans-sphenoidal adenoma resection was completed.
  
  
  RESULTS
  Pituitary TSH-secreting adenoma displayed positive sign in (99 m)Tc-octreotide scan. Antithyroid drug was of no help in depressing thyroid function to normal. However, octreotide treatment could revert thyroid function to normal rapidly. A significant shrinkage of tumor mass from 3.0 cm x 2.0 cm x 2.5 cm to 2.0 cm x 2.0 cm x 1.5 cm was observed and a shrinkage of thyroid gland from III to II also observed.
  
  
  CONCLUSIONS
  (99 m)Tc-octreotide scan is one of the useful tools for location diagnosis of TSH-secreting adenoma. Octreotide can effectively control central hyperthyroid and make tumor shrink, and it can be a satisfactory method of preoperative preparation for TSH-secreting adenoma.
authors.affiliation: Department of Endocrinology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
authors.forename: Shi
authors.initials: S
authors.lastname: Chen
authors.forename: Mei
authors.initials: M
authors.lastname: Li
authors.forename: Xiao-lan
authors.initials: XL
authors.lastname: Lian
authors.forename: Zheng-pei
authors.initials: ZP
authors.lastname: Zeng
authors.forename: Wei-xin
authors.initials: WX
authors.lastname: Dai
authors.forename: Fang
authors.initials: F
authors.lastname: Li
authors.forename: Wei
authors.initials: W
authors.lastname: Yu
authors.forename: Ren-zhi
authors.initials: RZ
authors.lastname: Wang
mesh_terms: D000236:Adenoma / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D015282:Octreotide / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D015609:Organotechnetium Compounds; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D013972:Thyrotropin / Q000378:metabolism*
chemical_list: C493098:99mTc-octreotide; D018931:Antineoplastic Agents, Hormonal; D015609:Organotechnetium Compounds; D013972:Thyrotropin; D015282:Octreotide